ClinConnect ClinConnect Logo
Search / Trial NCT06745544

Impact of Screening and Multicomponent Exercise on Fall Rates, Fractures, and Cardiovascular Health in Diabetes

Launched by AALBORG UNIVERSITY HOSPITAL · Dec 19, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Diabetes T1 D T2 D Ryma Falls Neuropathy Cvd Diabetic Complications Bone Health Fractures

ClinConnect Summary

The DIACTIVE study is a clinical trial looking at how a combination of health screenings and exercise can help prevent falls, fractures, and heart problems in older adults with diabetes. Specifically, it focuses on people aged 65 and older who have been living with diabetes for at least a year. The study aims to reduce fall rates by at least 30%, improve bone health, and enhance nerve function while also addressing heart health. Participants will go through various assessments to understand their health risks and will be assigned to personalized exercise programs that include strength and balance training, as well as medication when necessary.

To be eligible for the trial, participants need to be men or women aged 65 or older with either type 1 or type 2 diabetes. They should live independently and not have serious neurological or orthopedic conditions that would limit their ability to participate. Throughout the study, participants can expect regular follow-ups over five years to monitor their progress and the benefits of the program. The goal of this research is to improve the overall health and quality of life for older adults with diabetes and to gather insights that can shape future healthcare strategies for this population.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Men and women with either T1D or T2D with a minimum of 65 years of age with no upper limit.
  • 2. Living in their own home
  • 3. A diagnosis of diabetes at least one year prior to inclusion of the study to avoid honeymoon diabetes.
  • 4. Signed the informed consent.
  • Exclusion Criteria:
  • 1. No previous experience with rhythm-based multitask exercise.
  • 2. Having significant neurological diseases (e.g., Parkinson's and Multiple Sclerosis), vestibular diseases, or orthopedic surgeries (e.g., hip/knee replacement) affecting their ability to participate in the study.
  • 3. Having severely impaired cognitive function, defined as a score below 8 on the cognitive assessment "the short orientation-memory-concentration test."
  • 4. Being fully dependent on walking aids.
  • 5. Pregnancy or breast feeding
  • 6. Active malignancy or terminally ill.
  • 7. Not being able to understand Danish written and/or verbally.
  • 8. Participating in other interventional clinical studies within the last six months
  • 9. People with a weekly exercise activity above 5 hours a week

About Aalborg University Hospital

Aalborg University Hospital is a leading healthcare institution in Denmark, renowned for its commitment to advancing medical research and patient care. As a prominent clinical trial sponsor, the hospital actively engages in innovative studies aimed at improving health outcomes across various medical disciplines. With a focus on collaboration and interdisciplinary approaches, Aalborg University Hospital leverages its state-of-the-art facilities and expertise to conduct rigorous clinical trials, ensuring adherence to the highest ethical standards and regulatory requirements. The institution is dedicated to fostering a culture of research excellence, contributing valuable insights to the medical community and enhancing treatment options for patients.

Locations

Aalborg, Norh, Denmark

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported